IL117923D0 - Pyrido [2,3-d] pyrimidine derivatives and pharmaceutical compositions containing them - Google Patents

Pyrido [2,3-d] pyrimidine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL117923D0
IL117923D0 IL11792396A IL11792396A IL117923D0 IL 117923 D0 IL117923 D0 IL 117923D0 IL 11792396 A IL11792396 A IL 11792396A IL 11792396 A IL11792396 A IL 11792396A IL 117923 D0 IL117923 D0 IL 117923D0
Authority
IL
Israel
Prior art keywords
pyrido
pharmaceutical compositions
compositions containing
pyrimidine derivatives
pyrimidine
Prior art date
Application number
IL11792396A
Other versions
IL117923A (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/433,294 priority Critical patent/US5620981A/en
Priority to US08/611,279 priority patent/US5733914A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL117923D0 publication Critical patent/IL117923D0/en
Publication of IL117923A publication Critical patent/IL117923A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
IL11792396A 1995-05-03 1996-04-16 Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds IL117923A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/433,294 US5620981A (en) 1995-05-03 1995-05-03 Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
US08/611,279 US5733914A (en) 1995-05-03 1996-04-03 Pyrido 2, 3-d!pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation

Publications (2)

Publication Number Publication Date
IL117923D0 true IL117923D0 (en) 1996-08-04
IL117923A IL117923A (en) 2000-06-01

Family

ID=27029804

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11792396A IL117923A (en) 1995-05-03 1996-04-16 Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds

Country Status (20)

Country Link
EP (1) EP0823908B1 (en)
JP (1) JP3885116B2 (en)
CN (1) CN1083452C (en)
AT (1) AT344263T (en)
AU (1) AU713727B2 (en)
BG (1) BG62617B1 (en)
CA (1) CA2214219C (en)
CZ (1) CZ288160B6 (en)
DE (2) DE69636671T2 (en)
EA (1) EA000897B1 (en)
EE (1) EE03770B1 (en)
ES (1) ES2274526T3 (en)
HU (1) HU9801704A3 (en)
IL (1) IL117923A (en)
MX (1) MX9706529A (en)
NO (1) NO310110B1 (en)
NZ (1) NZ307021A (en)
PL (1) PL184093B1 (en)
SK (1) SK283952B6 (en)
WO (1) WO1996034867A1 (en)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW321649B (en) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
US5932574A (en) * 1995-04-27 1999-08-03 Zeneca Limited Quinazoline derivatives
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
TR199801530T2 (en) 1996-02-13 1998-11-23 Zeneca Limited quinazoline derivatives as VEGF inhibitors.
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE69709319T2 (en) 1996-03-05 2002-08-14 Astrazeneca Ab 4-anilinoquinazoline derivatives
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
US5945422A (en) * 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
JP2001509805A (en) * 1997-02-05 2001-07-24 ワーナー−ランバート・コンパニー Pyrido as cell growth inhibitors [2,3-d] pyrimidine and 4-amino-pyrimidine
EP1806348A3 (en) * 1997-02-05 2008-01-02 Warner-Lambert Company LLC Pyrido [2, 3 -d] pyrimidines and 4-amino-primidines as inhibitors of cellular proliferation
US6498163B1 (en) 1997-02-05 2002-12-24 Warner-Lambert Company Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
GB9716231D0 (en) 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues
EP1801112A1 (en) * 1998-05-26 2007-06-27 Warner-Lambert Company LLC Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
AT402177T (en) * 1998-05-26 2008-08-15 Warner Lambert Co Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cell reproduction
CA2347474C (en) * 1998-10-23 2008-08-26 F. Hoffmann-La Roche Ag Bicyclic nitrogen heterocycles
IL149230D0 (en) 1999-10-21 2002-11-10 Hoffmann La Roche Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
YU29102A (en) 1999-10-21 2004-12-31 F.Hoffmann-La Roche Ag. Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
ES2306306T3 (en) 1999-11-05 2008-11-01 Astrazeneca Ab New derivatives of quinazolina.
AU2576501A (en) * 1999-12-08 2001-06-18 Advanced Medicine, Inc. Protein kinase inhibitors
US20020002169A1 (en) 1999-12-08 2002-01-03 Griffin John H. Protein kinase inhibitors
JP2004505974A (en) 2000-08-04 2004-02-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニーWarner−Lambert Companyllc Method for producing 2- (4-pyridyl) amino-6-dialkyloxyphenylpyrido [2,3-d] pyrimidin-7-one
DE60113161T2 (en) 2000-08-04 2006-06-14 Warner Lambert Co Process for preparation of 2- (4-pyridyl) amino-6-dialkylolxaphenyl-pyrido (2,3-d) pyrimidone-7-on derivatives
US6518276B2 (en) 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
AT298751T (en) * 2000-08-31 2005-07-15 Hoffmann La Roche 7-oxopyridoryrimidine
CN1275964C (en) * 2000-08-31 2006-09-20 霍夫曼-拉罗奇有限公司 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
US6506749B2 (en) 2000-08-31 2003-01-14 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (I)
RU2269527C2 (en) 2001-02-12 2006-02-10 Ф.Хоффманн-Ля Рош Аг Derivatives of pyridopyrimidines, methods for their preparing and pharmaceutical composition based on thereof
JP4508645B2 (en) * 2002-01-04 2010-07-21 ザ ロックフェラー ユニバーシティー Compositions and methods for the prevention and treatment of amyloid-beta peptide related diseases
AT314370T (en) 2002-01-22 2006-01-15 Warner Lambert Co 2- (pyridin-2-ylamino) -pyrido (2,3-d) pyrimidin-7-one
US6822097B1 (en) 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
PA8577501A1 (en) 2002-07-25 2004-02-07 Warner Lambert Co Kinase inhibitors
RU2324695C2 (en) 2002-08-06 2008-05-20 Ф.Хоффманн-Ля Рош Аг 6-ALCOXYPYRIDOPYRIMIDINES AND PHARMACEUTICAL COMPOUND POSSESSING ACTIVITY OF MAP p38 KINASE INHIBITORS
CN1717396A (en) * 2002-11-28 2006-01-04 舍林股份公司 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
CN100420687C (en) * 2002-12-20 2008-09-24 霍夫曼-拉罗奇有限公司 Pyridino [2, 3-D] pyrimidine derivatives as selective KDR and FGFR inhibitors
US7098332B2 (en) * 2002-12-20 2006-08-29 Hoffmann-La Roche Inc. 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
US7449582B2 (en) * 2003-10-08 2008-11-11 Irm Llc Compounds and compositions as protein kinase inhibitors
KR100816321B1 (en) 2003-11-13 2008-03-24 에프. 호프만-라 로슈 아게 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
CA2555724A1 (en) * 2004-02-18 2005-09-09 Warner-Lambert Company Llc 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
WO2005105097A2 (en) * 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
DE102004029784A1 (en) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel 2-Benzylaminodihydropteridinones, process for their preparation and their use as medicaments
DE102004033670A1 (en) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg New pyridodihydropyrazinone, process for its preparation and its use as a medicament
FR2873118B1 (en) 2004-07-15 2007-11-23 Sanofi Synthelabo Pyrido-pyrimidine derivatives, their application in therapeutics
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
EP1630163A1 (en) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinones, methods for their preparation and their use as drugs
JP2008510770A (en) * 2004-08-26 2008-04-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel pteridinone as a PLK inhibitor
DE102004058337A1 (en) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of fused piperazin-2-one derivatives
FR2887882B1 (en) 2005-07-01 2007-09-07 Sanofi Aventis Sa Pyrido [2,3-d] pyrimidine derivatives, their preparation, their therapeutic application
KR20080045279A (en) * 2005-09-14 2008-05-22 얀센 파마슈티카 엔.브이. 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
TW200800983A (en) 2005-09-14 2008-01-01 Janssen Pharmaceutica Nv 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
US7642270B2 (en) 2005-09-14 2010-01-05 Janssen Pharmaceutica N.V. 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
RS52953B (en) * 2005-10-07 2014-02-28 Exelixis Inc. Pyridopyrimidinone inhibitors of pi3 kalpha
JP5480503B2 (en) * 2005-10-07 2014-04-23 エクセリクシス, インク. PI3Kα pyridopyrimidinone type inhibitor
FR2896246B1 (en) * 2006-01-13 2008-08-15 Sanofi Aventis Sa Pyrido-pyrimidone derivatives, their preparation, their therapeutic application
ES2329419T3 (en) 2006-01-31 2009-11-25 F. Hoffmann-La Roche Ag 7h-pirido (3,4-d) pirimidin-8-onas, its preparation and use as inhibitors of kinase proteins.
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP2076266A2 (en) * 2006-05-31 2009-07-08 The Board of Trustees of the Leland Stanford Junior University Method of treating inflammatory diseases using tyroskine kinase inhibitors
PL2074122T3 (en) 2006-09-15 2011-10-31 Pfizer Prod Inc Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
EP1914234A1 (en) 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
JO2985B1 (en) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co MAPK/ERK Kinase Inhibitors
FR2910813B1 (en) 2006-12-28 2009-02-06 Sanofi Aventis Sa New therapeutic use for the treatment of leukemia
CA2683784A1 (en) * 2007-04-11 2008-10-23 Exelixis, Inc. Pyrido[2,3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
CN101711249A (en) * 2007-04-11 2010-05-19 埃克塞里艾克西斯公司 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
WO2010039740A1 (en) 2008-09-30 2010-04-08 Exelixis, Inc. PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα AND MTOR
WO2010071846A2 (en) * 2008-12-19 2010-06-24 Afraxis, Inc. Compounds for treating neuropsychiatric conditions
SG10201507362TA (en) 2009-08-05 2015-10-29 Intra Cellular Therapies Inc Novel Regulatory Proteins And Inhibitors
WO2011044535A2 (en) 2009-10-09 2011-04-14 Afraxis, Inc. 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
FR2955109B1 (en) 2010-01-08 2012-09-07 Sanofi Aventis 5-oxo-5,8-dihydro-pyrido [2,3-d] pyrimidine derivatives, their preparation and their therapeutic use
AR080151A1 (en) 2010-02-09 2012-03-14 Exelixis Inc Methods for treating cancer using inhibitors of pi pyridopyrimidinone 3k and mTOR inhibitors in combination with autophagy
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
BR112013025798A2 (en) * 2011-04-08 2016-12-20 Afraxis Holdings Inc 8-ethyl-6- (aryl) pyrido [2,3-d] pyrimidin-7 (8h) -ones for the treatment of cancer and nervous system disorders
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
CN104812756A (en) 2012-09-26 2015-07-29 曼凯德公司 Multiple kinase pathway inhibitors
JP2016525532A (en) 2013-07-26 2016-08-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN106749173A (en) * 2016-11-25 2017-05-31 吉林化工学院 A kind of preparation method of pyrimidine bipyridyliumses compound
WO2018213219A1 (en) * 2017-05-15 2018-11-22 University Of Houston System Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) * 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
DE69222637T2 (en) * 1991-05-10 1998-02-26 Rhone Poulenc Rorer Int To mono- and bicyclic aryl and heteroaryl derivatives having an inhibitory effect on the EGF and / or PDGF receptor tyrosine kinase
FR2706898B1 (en) * 1993-06-25 1995-09-08 Union Pharma Scient Appl
PT790997E (en) * 1994-11-14 2000-06-30 Warner Lambert Co 6-aryl pyridine-2,3-d | pyrimidines and naftiridines for inhibiting protein tyrosine kinase mediated cellular proliferation

Also Published As

Publication number Publication date
EE03770B1 (en) 2002-06-17
EA199700356A1 (en) 1998-06-25
CN1083452C (en) 2002-04-24
HU9801704A3 (en) 1999-03-01
SK283952B6 (en) 2004-06-08
DE69636671D1 (en) 2006-12-14
BG62617B1 (en) 2000-03-31
DE69636671T2 (en) 2007-08-30
SK141097A3 (en) 1998-07-08
PL323089A1 (en) 1998-03-02
AT344263T (en) 2006-11-15
AU5576996A (en) 1996-11-21
ES2274526T3 (en) 2007-05-16
CA2214219A1 (en) 1996-11-07
HU9801704A2 (en) 1998-11-30
EE9700274A (en) 1998-06-15
BG102003A (en) 1998-12-30
NO310110B1 (en) 2001-05-21
NO975033L (en) 1997-10-31
JPH11504922A (en) 1999-05-11
MX9706529A (en) 1997-11-29
PL184093B1 (en) 2002-08-30
AU713727B2 (en) 1999-12-09
WO1996034867A1 (en) 1996-11-07
EP0823908B1 (en) 2006-11-02
CN1183099A (en) 1998-05-27
JP3885116B2 (en) 2007-02-21
CZ288160B6 (en) 2001-05-16
IL117923A (en) 2000-06-01
EA000897B1 (en) 2000-06-26
NO975033D0 (en) 1997-10-31
CA2214219C (en) 2008-09-30
EP0823908A1 (en) 1998-02-18
NZ307021A (en) 2001-04-27
CZ327597A3 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
NZ273617A (en) N-phenyl-2-pyrimidineamine derivatives pharmaceutical compositions
NZ283813A (en) 4-oxo-thieno[2,3-b]pyridine derivatives and medicaments
GR3029796T3 (en) Camptothecin derivatives
IL109526D0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
AU3701797A (en) Substituted pyrimidine derivatives and their pharmaceutical use
HU9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUT66302A (en) Imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions containing them and process for preparing them
SI1281400T1 (en) Pharmaceutical compositions containing ascomycin derivatives
AU6995396A (en) Pharmaceutical formulation
IL108486A (en) 9H-INDENO £1, 2-b|-2(1H)-ONE DERIVATIVES AND ANALOGS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
IL118369D0 (en) Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
NZ244906A (en) 2-ethyl-1h-imidazo[4,5-c]quinolin-4-amine derivatives and pharmaceutical compositions
ZA9300649B (en) N-sylfonyl-2-oxoindole derivatives, their preparation and pharmaceutical compositions containing them.
HU0003999A3 (en) Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them
NZ292909A (en) Pyrimido[5,4-d]pyrimidines; medicaments
HU0001805A3 (en) 6-benzyl-1,5-dihydro-pyrazolo[3,4-d]-pyrimidin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
NZ265547A (en) 10,11-methano-dibenzo-suberane derivatives, preparation and pharmaceutical compositions thereof
IL122464A (en) N-pyrazine-pyridinesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL90830D0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL105412D0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
NZ246917A (en) Carbapenems; derivatives, preparation and pharmaceutical compositions
HU9801602A3 (en) Imidazo[1,2-a]pyridine derivatives, process for their production, pharmaceutical compositions and use thereof
DE69804743T2 (en) Pyrazolo [4,3-d] pyrimidine derivatives and pharmaceutical preparations containing them
HU0004225A3 (en) Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees